Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply

被引：0
|
作者：
Zhao, Jianhui [1 ,2 ]
Xue, Erxu [3 ]
Liu, Zhanju [4 ,5 ]
Li, Xue [1 ,2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Big Data Hlth Sci, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Nursing Dept, Hangzhou, Zhejiang, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Inflammatory Bowel Dis Res, Shanghai, Peoples R China
[5] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/apt.18414
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [1] Editorial: Allostatic Load and Inflammatory Bowel Disease
    Mendoza, Jeli
    Irwin, James
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (01) : 188 - 189
  • [2] Editorial: diagnostic precision of iron deficiency in inflammatory bowel disease. Authors' reply
    Daude, Sebastien
    Gastin, Isabelle
    Peyrin-Biroulet, Laurent
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (02) : 401 - 401
  • [3] Editorial: anxiety and depression in inflammatory bowel disease - authors' reply
    Stapersma, Luuk
    van den Brink, Gertrude
    Szigethy, Eva M.
    Escher, Johanna C.
    Utens, Elisabeth M. W. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (06) : 687 - 688
  • [4] Letter: Allostatic Load and Adverse Prognosis in Inflammatory Bowel Disease-Need More Evidence. Authors' Reply
    Zhao, Jianhui
    Xue, Erxu
    Liu, Zhanju
    Li, Xue
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1485 - 1486
  • [5] Editorial: treating strictures in inflammatory bowel disease-authors' reply
    Rieder, Florian
    Feagan, Brian G.
    Jairath, Vipul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1313 - 1314
  • [6] Editorial: Can We Prevent Inflammatory Bowel Disease? Authors' Reply
    Ho, Fai Fai
    Wu, Irene Xin-Yin
    Chung, Vincent Chi Ho
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025,
  • [7] Editorial: natural history of irritable bowel syndrome in inflammatory bowel disease-authors' reply
    Fairbrass, Keeley M.
    Hamlin, P. John
    Gracie, David J.
    Ford, Alexander C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (08) : 1302 - 1303
  • [8] The Authors Reply: Pursuing the Optimal Operationalization of Allostatic Load
    Wiley, Joshua F.
    Gruenewald, Tara L.
    Karlamangla, Arun S.
    Seeman, Teresa E.
    PSYCHOSOMATIC MEDICINE, 2017, 79 (01): : 119 - 121
  • [9] Editorial: concurrence of coeliac disease with inflammatory bowel disease - is big data the final arbiter? Authors' reply
    Sonnenberg, Amnon
    Genta, Robert M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1155 - 1156
  • [10] Treatment of anaemia in inflammatory bowel disease: authors' reply
    de Silva, A
    Rampton, DS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1274 - 1275
12345